International Co-operation Heads Regulatory Plans in Japan Faraz Kermani talks to top-level officials from Japan's Pharmaceuticals and Medical Devices Agency about the country's regulatory strategies.

摘要

Japan's Pharmaceuticals and Medical Devices Agency is set to undergo a significant change, with its focus shifting towards increased co-operation on the international stage. In its second mid-term plan, published on the PMDA's website in April, the agency outlined its plans to "play an active role within the international community from a global perspective by promoting international harmonisation".